Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nancy Chang


Dr. Nancy Chang serves as Chief Executive Officer & Board Member at Ansun Biopharma. Nancy was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors from 2007 to 2012. From 1987 to 2007, Dr. Chang served as Co-Founder, President and Chairman of Tanox, Inc., which was sold to Genentech in 2007. Prior to founding Tanox, Dr. Chang held several leadership positions at Centocor, now a division of Johnson & Johnson. She was also an Associate Professor at Baylor College of Medicine. She has served on the board of a number of companies, including SciClone Pharmaceuticals, Inc., Charles River Laboratories International, Inc., Applied Optoelectronics Inc. Nancy received her Doctorate in Biological Chemistry from Harvard University.

Primary Investor Type
Angel (individual)
Primary Office
  • 3030 Callan Road
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000

Nancy Chang Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Rgenix 31-Jul-2015 Early Stage VC 000 Drug Discovery Clinical Trials - Phase 1 00000 00000 00.0
0000000 19-Jun-2015 00000 00000 00.00 Monitoring Equipment Generating Revenue 00000 00000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nancy Chang’s full profile, request a free trial.

Nancy Chang Team (1)

Name Title Deals Funds Boards Office Contact
Nancy Chang Ph.D Angel Investor 0 0 0 San Diego, CA